Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2126-2131
Published online before print August 14, 2003, doi: 10.1161/01.STR.0000086754.32238.DA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/9/2126    most recent
01.STR.0000086754.32238.DAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strandberg, T. E.
Right arrow Articles by Tilvis, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strandberg, T. E.
Right arrow Articles by Tilvis, R. S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bacterial Infections
*Viral Infections
Related Collections
Right arrow Behavioral/psychosocial - stroke
Right arrow Other Research

(Stroke. 2003;34:2126.)
© 2003 American Heart Association, Inc.


Original Contributions

Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly Persons With Cardiovascular Diseases

Timo E. Strandberg, MD, PhD; Kaisu H. Pitkala, MD, PhD; Kimmo H. Linnavuori, MD, PhD Reijo S. Tilvis, MD, PhD

From the Department of Medicine, Geriatric Clinic, and Department of Virology, University of Helsinki, Helsinki, Finland.

Correspondence to Timo E. Strandberg, MD, Department of Medicine, Geriatric Clinic, University of Helsinki, PO Box 340, FIN-00029 HUS Helsinki, Finland. E-mail timo.strandberg{at}hus.fi

Background and Purpose— Inflammation and infectious etiology have been implicated in the pathogenesis of dementia. We sought to investigate whether the seropositivity of common infections was associated with cognitive function.

Methods— Viral burden (seropositivity for herpes simplex virus type 1 [HSV-1], herpes simplex virus type 2 [HSV-2], or cytomegalovirus [CMV]) and bacterial burden (Chlamydia pneumoniae and Mycoplasma pneumoniae) were related to cognitive status and its impairment among 383 home-dwelling elderly with cardiovascular diseases (mean age, 80 years). The Mini-Mental State Examination (MMSE) and its changes and the Clinical Dementia Rating (CDR) were used to define cognitive impairment.

Results— At baseline, 0 to 1, 2, and 3 positive titers toward viruses were found in 48 (12.5%), 229 (59.8%), and 106 individuals (27.7%), respectively. MMSE points decreased with increasing viral burden (P=0.03). At baseline, 58 individuals (15.1%) had cognitive impairment, which after adjustments was significantly associated with seropositivity for 3 viruses (hazard ratio, 2.5; 95% CI, 1.3 to 4.7). MMSE score decreased in 150 (43% of 348) during 12-month follow-up. After adjustment for MMSE score at baseline and with 0 to 1 seropositivities as reference (1.0), the hazard ratios were 1.8 (95% CI, 0.9 to 3.6) and 2.3 (95% CI, 1.1 to 5.0) for 2 and 3 seropositivities, respectively. The prevalence of possible or definite dementia according to CDR also increased with viral burden. No significant associations were observed between bacterial burden and cognition.

Conclusions— Viral pathogen burden of HSV and CMV was associated with cognitive impairment in home-dwelling elderly persons with cardiovascular diseases. The results need to be tested in larger databases, but they may offer a preventable cause of cognitive decline.


Key Words: bacteremia • dementia • herpes simplex • neuropsychological tests • viral proteins




This article has been cited by other articles:


Home page
JAMAHome page
T. E. Strandberg, K. H. Pitkala, and R. S. Tilvis
Cytomegalovirus Antibody Level and Mortality Among Community-Dwelling Older Adults With Stable Cardiovascular Disease
JAMA, January 28, 2009; 301(4): 380 - 382.
[Full Text] [PDF]


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]